EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.23.47 | medicine | potential target for chemotherapy of virus infection and associated diseases, essential for maturation of infectious virions, development of drugs against the protease should be effective against HIV-2 | Human immunodeficiency virus 2 |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.4.23.47 | - |
Human immunodeficiency virus 2 |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
3.4.23.47 | crystallized by hanging drop method in complex with a reduced amide inhibitor, BI-LA-398 | Human immunodeficiency virus 2 |
3.4.23.47 | crystals grown by hanging-drop vapor diffusion method, thin tetragonal prisms, space group P4(1)2(1)2 or P4(3)2(1)2 with a=b=62.6 A and c=115.8 A | Human immunodeficiency virus 2 |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.23.47 | 2,6-dimethylbenzyl (2S,3R)-4-((2S,4R)-2-(tert-butylcarbamoyl)-4-(4,6-dimethylpyrimidin-2-ylthio)piperidin-1-yl)-3-hydroxy-1-phenylbutan-2-ylcarbamate | hydroxyethylamine dipeptide isostere inhibitor 3 | Human immunodeficiency virus 2 | |
3.4.23.47 | 2,6-dimethylbenzyl (2S,3R)-4-((2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-3-ylmethoxy)piperidin-1-yl)-3-hydroxy-1-phenylbutan-2-ylcarbamate | hydroxyethylamine dipeptide isostere inhibitor 5 | Human immunodeficiency virus 2 | |
3.4.23.47 | 2,6-dimethylbenzyl (2S,3R)-4-((2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-3-ylthio)piperidin-1-yl)-3-hydroxy-1-phenylbutan-2-ylcarbamate | hydroxyethylamine dipeptide isostere inhibitor 2 | Human immunodeficiency virus 2 | |
3.4.23.47 | 2,6-dimethylbenzyl (2S,3R)-4-((2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-4-ylsulfonyl)piperidin-1-yl)-3-hydroxy-1-phenylbutan-2-ylcarbamate | hydroxyethylamine dipeptide isostere inhibitor 4 | Human immunodeficiency virus 2 | |
3.4.23.47 | 2,6-dimethylbenzyl (2S,3R)-4-((2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-4-ylthio)piperidin-1-yl)-3-hydroxy-1-phenylbutan-2-ylcarbamate | hydroxyethylamine dipeptide isostere inhibitor 1 | Human immunodeficiency virus 2 | |
3.4.23.47 | N-((S)-1-((2S,3R)-4-((2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-3-ylmethoxy)piperidin-1-yl)-3-hydroxy-1-phenylbutan-2-ylamino)-3-methyl-1-oxobutan-2-yl)quinoline-2-carboxamide | hydroxyethylamine dipeptide isostere inhibitor 8 | Human immunodeficiency virus 2 | |
3.4.23.47 | N-((S)-1-((2S,3R)-4-((2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-3-ylmethylthio)piperidin-1-yl)-3-hydroxy-1-phenylbutan-2-ylamino)-3-methyl-1-oxobutan-2-yl)quinoline-2-carboxamide | hydroxyethylamine dipeptide isostere inhibitor 6 | Human immunodeficiency virus 2 | |
3.4.23.47 | N-((S)-1-((2S,3R)-4-((2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-3-ylthio)piperidin-1-yl)-3-hydroxy-1-phenylbutan-2-ylamino)-3-methyl-1-oxobutan-2-yl)quinoline-2-carboxamide | hydroxyethylamine dipeptide isostere inhibitor 7 | Human immunodeficiency virus 2 |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.23.47 | GAG precursor protein of HIV-2 + H2O | Human immunodeficiency virus 2 | - |
? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.23.47 | Human immunodeficiency virus 2 | - |
human immunodeficiency virus type 2 | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.23.47 | - |
Human immunodeficiency virus 2 |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.23.47 | GAG precursor protein of HIV-2 + H2O | - |
Human immunodeficiency virus 2 | ? | - |
? | |
3.4.23.47 | additional information | catalyzes hydrolysis of Phe-Pro, Tyr-Pro and other peptide bonds in the gag and gag-pol polyproteins | Human immunodeficiency virus 2 | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.4.23.47 | dimer | 2 identical subunits, homodimer | Human immunodeficiency virus 2 |